Skip to search formSkip to main contentSkip to account menu

DF 521

Known as: DF-521 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Objective To evaluate the efficacy of batroxobin (DF-521) in the treatment of cor pulmonale in acute exacerbation phase. Methods… 
2006
2006
Objective To investigate whether DF-521 can promote early collateral and microvascular formation in brain after focal cerebral… 
2004
2004
OBJECTIVE This study was designed to use urokinase (UK) in combination with batroxobin in thrombolytic therapy so as to see… 
2002
2002
Objective:To observe the therapeutic effect and safety rate of DF 521(Defibrin) in combination with fructose diphosphate in the… 
2002
2002
Objective To observe the effect of DF 521 on acute brain infarction and its' safety.Method Patients were randomly divided into DF… 
1998
1998
OBJECTIVE To investigate the level of plasma tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI), 6-keto… 
1997
1997
AIM: To observe the effects of batroxobin (DF-521) on platelet aggregation and myocardial ischemia of the patients with unstable… 
1997
1997
AIM: To observe the clinical effects of batroxobin (DF_521) in the treatment of acute cerebral embolism. METHODS: Forty-eight… 
1996
1996
  • H. Er
  • 1996
  • Corpus ID: 76344388
AIM:To study the effect of batroxobin(DF-521)in treating acute myocardial infarction(AMI).METHODS:Twenty-four patients with AMI(M…